FindTrial
Sign In

Incidence,risk factors and management of chemotherapy hypersensitivity in pediatric malignancies from a tertiary care center in Thailand

Incidence,risk factors and management of chemotherapy hypersensitivity in pediatric malignancies from a tertiary care center in Thailand

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20200607001
Enrollment
Unknown
Registered
2020-06-07
Start date
2019-07-31
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypersensitivity reactions to chemotherapy hypersensitivity reactions to chemotherapy incidence risk factors clinical feature treatment outcome

Interventions

children with malignancies who had hypersentivity reactions to chemotherapy,children with malignancies who didn&#39
t have hypersentivity reactions to chemotherapy
Health Services Research,Health Services Research
Case group,Control group

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: Children age less than 18 years old History of malignancy previously visited at hematology/oncology clinic at Siriraj hospital

Exclusion criteria

Exclusion criteria: No

Design outcomes

Primary

MeasureTime frame
Incidence of hypersensitivity reactions to chemotherapy past 10 years chart review—

Secondary

MeasureTime frame
Risk factors of hypersensitivity reactions to chemotherapy in Thai children at enrollment chart review—

Countries

Thailand

Contacts

Public ContactPunchama Pacharn

Siriraj Hospital

punchama@gmail.com0909839104

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026